Printer Friendly

Strong LecTec NatusPatch(R) sales on QVC: New pharmaceutical production line to meet growing retail demand.

MINNETONKA, Minn.--(BUSINESS WIRE)--Feb. 9, 1995--LecTec Corp. today announced that its NatusPatch(R), a patented analgesic patch that relieves minor backaches, arthritis and muscular pains, has been generating substantial sales during recent showings on the QVC home shopping channel.

The company said QVC sold out its entire NatusPatch inventory during two showings on Feb. 6. Two selling sessions in early January were also sell-outs.

To meet demand from anticipated future QVC showings and additional retail initiatives, the company said it is investing in a new pharmaceutical production line dedicated to patch products. The new line, which will have approximately five times the capacity of the existing line, will commence volume production by early summer.

The company said it expects to manufacture a growing range of patch products, utilizing LecTec's proprietary membrane technology, on the new equipment. The new production line is being supported entirely with internally-generated cash.

The NatusPatch is distributed by Natus Corp., a subsidiary of LecTec.

LecTec develops, manufactures and markets skin-related medical products based on patented hydrogel membrane technology. The company's core businesses include diagnostic electrodes for electrocardiography and medical tapes. The company is focusing an extensive R&D effort on its emerging therapeutic products business. LecTec common stock is traded on the NASDAQ National Market System under the symbol LECT.

CONTACT: LecTec Corp., Minnetonka

Erwin W. Templin II, 612/933-2291 or fax: 612/933-4808
COPYRIGHT 1995 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1995, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 9, 1995
Previous Article:Cambior announces its 1994 production results.
Next Article:New Air France summer schedule brings more of Europe to Houston.

Related Articles
LecTec's NatusPatch(R) scheduled for a variety of broadcasts on QVC.
Cashing in on the home shopping boom.
LecTec analgesic pain patches to be marketed through half-hour television "infomercial".
LecTec signs letter of intent for strategic marketing alliance with CNS Inc.; Maker of Breathe Right nasal strips plans to market LecTec's analgesic...
LecTec announces agreement in principle to sell direct marketing business of Natus subsidiary; Company to continue electronic media and retail...
LecTec Secures Additional Patent Positions on Products for Smoking Cessation and Human Body Weight Management.
Bradley Pharmaceuticals And LecTec To Collaborate On Dermatological Patches.
LecTec Ships First Major Retail Orders for Therapatch Vapor Under Tim Quinn as Director of Consumer Products Division.
Co-CFO cable guys' focus: dual revenue streams. (Cover Story).

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters